Nanobody: a small antibody with big implications for tumor therapeutic strategy

S Sun, Z Ding, X Yang, X Zhao, M Zhao… - International Journal …, 2021 - Taylor & Francis
The development of monoclonal antibody treatments for successful tumor-targeted therapies
took several decades. However, the efficacy of antibody-based therapy is still confined and …

Pharmacological targeting of AKAP-directed compartmentalized cAMP signalling

A Dema, E Perets, MS Schulz, VA Deák, E Klussmann - Cellular signalling, 2015 - Elsevier
The second messenger cyclic adenosine monophosphate (cAMP) can bind and activate
protein kinase A (PKA). The cAMP/PKA system is ubiquitous and involved in a wide array of …

[HTML][HTML] Camelid single-domain antibodies: historical perspective and future outlook

M Arbabi-Ghahroudi - Frontiers in immunology, 2017 - frontiersin.org
Tremendous effort has been expended over the past two and a half decades to understand
many aspects of camelid heavy chain antibodies, from their biology, evolution, and …

[HTML][HTML] The preclinical pharmacology of the high affinity anti-IL-6R Nanobody® ALX-0061 supports its clinical development in rheumatoid arthritis

M Van Roy, C Ververken, E Beirnaert… - Arthritis research & …, 2015 - Springer
Introduction The pleiotropic cytokine interleukin-6 (IL-6) plays an important role in the
pathogenesis of different diseases, including rheumatoid arthritis (RA). ALX-0061 is a …

[HTML][HTML] A novel CD7 chimeric antigen receptor-modified NK-92MI cell line targeting T-cell acute lymphoblastic leukemia

F You, Y Wang, L Jiang, X Zhu, D Chen… - American journal of …, 2019 - ncbi.nlm.nih.gov
Chimeric antigen receptor (CAR) immunotherapy has recently shown promise in clinical
trials for B-cell malignancies; however, designing CARs for T-cell based diseases remain a …

Camelid single-domain antibodies: A versatile tool for in vivo imaging of extracellular and intracellular brain targets

T Li, M Vandesquille, F Koukouli, C Dudeffant… - Journal of Controlled …, 2016 - Elsevier
Detection of intracerebral targets with imaging probes is challenging due to the non-
permissive nature of blood-brain barrier (BBB). The present work describes two novel single …

[HTML][HTML] Immuno-targeting the multifunctional CD38 using nanobody

T Li, S Qi, M Unger, YN Hou, QW Deng, J Liu, C Lam… - Scientific Reports, 2016 - nature.com
CD38, as a cell surface antigen is highly expressed in several hematologic malignancies
including multiple myeloma (MM) and has been proven to be a good target for …

[HTML][HTML] South American Camelids: their values and contributions to people

B Vilá, Y Arzamendia - Sustainability Science, 2022 - Springer
Abstract South American Camelids (SACs) make several material and non-material
contributions to people and are a key component of the Andean biocultural heritage. From …

[HTML][HTML] Identification of antiviral peptide inhibitors for receptor binding domain of SARS-CoV-2 omicron and its sub-variants: an in-silico approach

S Singh, HN Banavath, P Godara, B Naik, V Srivastava… - 3 Biotech, 2022 - Springer
Omicron, a variant of concern (VOC) of SARS-CoV-2, emerged in South Africa in November
2021. Omicron has been continuously acquiring a series of new mutations, especially in the …

Nanobody conjugated PLGA nanoparticles for active targeting of African Trypanosomiasis

JL Arias, JD Unciti-Broceta, J Maceira… - Journal of Controlled …, 2015 - Elsevier
Targeted delivery of therapeutics is an alternative approach for the selective treatment of
infectious diseases. The surface of African trypanosomes, the causative agents of African …